#Amgen November 9
We may earn money or products from the companies mentioned in this post.
Throughout November 2024, several of us are taking part in the 30-Day Dow Jones Coach4aday Challenge. Each day, we explore the history or learn about a company within the DJIA—a key economic and stock market indicator. Today’s post is on AMGEN.
Amgen, founded in 1980 as Applied Molecular Genetics, Inc., is a pioneering biotechnology company that initially focused on utilizing recombinant DNA technology to develop novel therapeutics. One of their drugs is called Epogen, used to a treat anemia in patients with kidney disease, which became one of the first blockbuster biologic drugs.
Amgen joined the Dow Jones Industrial Average (DJIA) on August 31, 2020. It replaced Pfizer, marking a shift in the index to include more biotechnology and innovative healthcare companies.
Dow Jones 30-Day Challenge Guidelines
Like previous challenges there are no hard and fast rules to participate. There are a few suggested guidelines
- Each day in November 2024 write about the history or a company that makes up the Dow Jones.
- Share at least one fact about that company.
- If so inclined use the hash tag #Coach4adayChallenge on social media platforms
November 9th-Amgen
When the company started in 1980 it had 3 employees. In its first three years, Amgen explored several innovative ideas, including developing organisms designed to extract oil from shale.
Amgen’s stock price at its initial public offering (IPO) in 1983 was $18 per share. When it joined the Dow in 2020 it was $248.43 a share. On November 6, 2024, the stock closed at $321.07
Recent Comments